OBJECTIVE: Treatment adherence in @entity1 with @entity1277 ( @entity1277 ) in Iceland is unknown. The aim of the study was to investigate treatment drop-out and explore factors that influence premature termination of treatment in a specialized @entity1277 treatment unit, at the University Hospital of Iceland, during the period of September 1, 2008 - @entity4456 , 2012. MATERIAL AND METHODS: The study is retrospective and naturalistic. Hospital records of referred @entity1 were examined. Those meeting the ICD 10 @entity1278 ( @entity1278 ) (F50.0, F50.1), @entity1279 ( @entity1279 ) (F50.2, F50.3) and @entity1277 not otherwise specified (EDNOS) (F50.9) were included. The total sample was 260 and 182 @entity1 met inclusion criteria. No-shows were 7%. Drop-out was defined as premature termination of treatment without formal discharge. RESULTS: The sample consisted of 176 @entity1 and 6 @entity1 , mean age 26.3 years. @entity1279 was diagnosed in 52.7% of @entity1 , EDNOS in 36.8% @entity1278 in 10.4%. 74.7% had one or more co-morbid @entity146 diagnosis. @entity308 were diagnosed in 72.5%, @entity71 in 15.4% and @entity1314 in 8.2%. Lifetime prevalence of @entity734 ( @entity734 ) was 30.8%. Drop-out from treatment occurred in 54.4% of cases (with approximately 1/3 returning to treatment), 27.5% finished treatment and 18.1% were still in treatment at the end of the follow up period. Treatment adherence was significantly higher in @entity1 who had a university degree, in those who had themselves taken the initiative to seek @entity1277 treatment and in those with higher @entity148 scores at assessment. @entity1278 @entity1 did better than other @entity1277 @entity1 while @entity1 with @entity734 showed a tendency for higher drop-out (p=0.079). CONCLUSION: The drop-out rates were similar to what has been reported from other western countries. Follow-up time was longer and @entity1278 @entity1 did better than expected. Higher education, initiative in seeking treatment and higher @entity148 scores on questionnaires were protective.

[Eating Disorder Treatment in Iceland - Treatment adherence, XXXX co-morbidities and factors influencing drop-out].

@entity1 :: ('9606', 'Species') :: ['men', 'women', 'patients', 'patient'] @entity308 :: ('MESH:D003866', 'Disease') :: ['Anxiety- and/or depression'] @entity146 :: ('MESH:D001523', 'Disease') :: ['psychiatric'] @entity71 :: ('MESH:D001289', 'Disease') :: ['Attention hyperactivity deficiency disorder'] @entity1278 :: ('MESH:D000856', 'Disease') :: ['AN', 'criteria of anorexia nervosa'] @entity148 :: ('MESH:D001008', 'Disease') :: ['anxiety'] @entity1277 :: ('MESH:D001068', 'Disease') :: ['eating disorder', 'eating disorders', 'ED'] @entity4456 :: ('5580', 'Gene') :: ['May 1'] @entity1279 :: ('MESH:D052018', 'Disease') :: ['BN', 'bulimia nervosa'] @entity1314 :: ('MESH:D010554', 'Disease') :: ['personality disorders'] @entity734 :: ('MESH:D019966', 'Disease') :: ['SUDs', 'substance use disorders']
@entity146 :: (MESH:D001523,Disease) :: ['psychiatric']
